No category found.

  • To immediately accept the subgroup findings.
  • To urgently caution that post-hoc subgroup analyses can lead to spurious findings due to multiple comparisons, requiring independent validation.
  • To disregard the main study results.
  • To encourage more such analyses.
  • To share data with anyone who asks.
  • To urgently implement robust data anonymization, security protocols, and obtain appropriate ethical approvals to protect patient privacy and confidentiality.
  • To collect as much data as possible without consent.
  • To only focus on statistical analysis.
  • To immediately implement the program.
  • To urgently explain that for rare diseases, a high positive predictive value (PPV) is difficult to achieve, leading to unnecessary anxiety and follow-up for many healthy individuals.
  • To ignore the concept of false positives.
  • To use a less sensitive test.
  • To immediately adopt the new therapy.
  • To urgently advise that conclusions should not be based on a single study, especially close to the significance threshold, and that replication and meta-analysis are critically important.
  • To ignore all p-values.
  • To assume one study is enough.
Scroll to Top